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Abstract – Epigallocatechin-3-gallate (EGCG), the major catechin 
present in green tea, displays diverse biological activities as anti-
oxidation, anti-inflammation, anti-proliferation and anti-microbial 
among others. In the present work it was evaluated the effect of the 
consumption of EGCG along 90 days on healthy human volunteers 
(n=30) on plasma molecular signature acquired by mid-infrared 
(MIR) spectroscopy. It was observed by principal component 
analysis of spectra that plasma samples presented a significant 
different molecular profile after 90 days of EGCG consumption. 
Based on the corresponding loading vector, it was observed that 
EGCG consumption affected the profile of the major molecules as 
proteins and lipids.  Were identified diverse ratios of spectral bands 
statistically different (p < 0.01) after EGCG consumption, according 
to a high impact of EGCG on the general metabolism. MIR 
spectroscopy enabled to acquire the plasma whole molecular 
signature in a highly sensitive and specific mode. Since the MIR 
spectra is also acquired in an economic, simple, fast and high-
throughput mode, the technique presents promising characteristics to 
acquire information in large-scale epidemiological studies towards a 
better understand of the in vivo effect of EGCG.  
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I. INTRODUCTION 
 
Tea, namely black and green tea, is the most consumed 
beverage in the world after water [1]. From the bioactive 
compounds present in green tea, diverse studies have focused 
their attention in epigallocatechin-3-gallate (EGCG), the most 
abundant polyphenols isolated from it. EGCG presents diverse 
biological activities as anti-oxidant, anti-inflammatory, anti-
carcinogenic and anti-microbial agent, leading in recent years 
to an increase of new products supplemented with extracts of 
green tea (reviewed in Hu et al. [2]).  
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EGCG has been associated to regulate mitochondria 
biogenesis, metabolism as bioenergetic and even 
mitochondria-mediated cell cycle and apoptosis (reviewed in 
Shi et al. [3]). EGCG inhibits Toll-Like receptors 4 (TLR4) 
[4] which induces the production of pro-inflammatory 
cytokines, chemokine and is associated with cancer 
progression. Therefore, the EGCG inhibition of TLR4 will act 
as anti-inflammatory while reducing cancer progression. 
Diverse in vivo studies, focusing animal models, have also 
pointed the EGCG activity in inhibiting cancer cells 
proliferation and migration, as conducted by Luo et al. [5], in 
in vitro bladder cancer cells, showing that EGCG induced 
apoptosis via caspases-8, -9 and -3, Bax, Bcl-2 and PARP 
pathways, and in vivo on mice, showing a decrease in tumour 
volume, by down-regulation of nuclear factor-kappa B and 
matrix metalloproteinase-9. 
 
EGCG might present opposite activities in function of the cells 
metabolic status, e.g., may present anti-oxidative activity in 
“normal” cells and pro-oxidative to counteract cancer cells [3]. 
One method to direct the EGCG activity is for example to  
target it to specific cell receptors, as conducted by Sanna et al. 
[6] that developed polymeric EGCG-encapsulated 
nanoparticles targeting prostate specific membrane antigens. 
These researchers observed an enhanced anti-proliferative 
activity in prostate cancer (PCa) cell lines.  
 
The present work aims to evaluate the effect of the 
consumption of EGCG on the plasma whole molecular 
signature based on mid-infrared (MIR) spectroscopy. This 
analytical technique detects the fundamental vibration modes 
present in biomolecules of a high diversity of functional 
groups in biological samples, such as C-C, C=C, C-O, C=O, 
CN, CP, CH, PO, CP, OH, NH, among others. The acquisition 
of the complete molecular signature based on this technique 
benefits from a high sensitivity and specificity, making it a 
prime candidate for research in the field of diagnosis and 
prognosis of diverse diseases as infectious [7], 
neurodegenerative and cancer [8,9].  
 
 
 
II. MATERIALS AND METHODS 
 
A. Biological assay  
All participants (n=30) provided a signed written informed 
consent before enrolment in the study approved by a research 
ethics committee.  Previous studies established that 400 mg to 
800 mg of EGCG intake are considered safe doses previously 
utilized in human clinical trials [10]. These doses result in 
peak serum concentrations in the range of 100 to 400 ng/ml 
[11]. In this study, participants took 225mg of EGCG present 
in commercial capsules each day for 90 days. Blood samples 
were taken just before the start of the assay (T-0) and at the 
end of the 90 days. Plasma was obtained by centrifugation 
fresh blood sample 3500 rpm for 10 min.  
 
B. MIR spectra acquisition   
Triplicates of 25 μL of plasma diluted at 1/10 were transferred 
to a 96-wells Si plate and then dehydrated for about 2.5 h, in a 
desiccator under vacuum. Spectral data was collected using a 
FTIR spectrometer (Vertex 70, Bruker) equipped with an 
HTS-XT (Bruker) accessory. Each spectrum represented 64 
coadded scans, with a 2cm−1 resolution, and was collected in 
transmission mode, between 400 and 4000 cm−1. The first well 
of the 96-wells plate did not contain a sample and the 
corresponding spectra was acquired and used as background, 
according to the HTS-XT manufacturer.  
 
C. Spectra pre-processing and processing  
Spectra were pre-processed by atmospheric correction, 
baseline correction and normalization to amide I peak. Second 
derivative spectra were computed from raw spectra using a 
Savitzky-Golay filter, and a 2rd order polynomial over a 15-
point window.  
 
Atmospheric and baseline corrections were conducted with 
OPUS® software, version 6.5 (Bruker, Germany) and all 
remaining pre-processing work and principal component 
analysis (PCA) was conducted with Matlab (Matworks, 
Natick, MA, USA).  
 
Absorbance ratios were determined based on spectra pre-
processed with atmospheric and baseline correction and 
normalization. To evaluate possible differences in the selected 
absorbance ratios a paired t-test was performed at 1% 
significance level. 
 
 
III. RESULTS AND DISCUSSION 
 
It was observed that 90 days of a daily consumption of 225 mg 
of EGCG affected diverse clinical outputs as the hematocrit, 
hemoglobin, reticulocyte hemoglobin and fetal hemoglobin 
content at 1% level of significance. 
 
 
 
 
 
 
 
 
Fig. 2. Spectra from plasma after atmospheric, baseline correction and 
normalization to amide I (A), the corresponding PC score-plot (B) and the 
loading vectors of PC-1 (C) and PC-2 (D). 
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The non-target metabolomics of plasma was acquired by MIR 
spectroscopy, as this technique retrieves the metabolic 
fingerprint of biological fluids and cells [8,12]. Fig. 1A 
represents the MIR spectra of plasma of 30 participants after 
atmospheric, baseline correction and normalization to amide I 
(at 1650cm-1), and Fig. 1B the corresponding score-plot of 
PCA. It was possible to observe in the score-plot of PC-1 
versus PC-2, which make up for 87% of data variance, a clear 
separation between all plasma samples taken just before the 
start of EGCG consumption (T0) when comparing to the 
plasma samples taken after 90 days (T90) of EGCG 
consumption. Therefore, the EGCG consumption significantly 
affected the plasma molecular composition. 
 
The loading vectors of PC-1 and PC-2 (Fig. 1C and 2D) 
highlight the spectra regions that contributed the most for 
plasma samples separation between T0 and T90. These were: 
amide A from proteins (between 3000 and 3500 cm-1); the 
methyl and methylene groups from lipids (between 2850 and 
2970 cm-1 and between 1300 to 1450 cm-1); amide I and II 
(1650 and 1550 cm-1) from proteins; phosphate groups (at 
1080 and 1240 cm-1) from nucleic acids, phospholipids and 
phosphorylated proteins; ribose from nucleic acids (at 1125 
and 1170 cm-1); and the fingerprint region between 400 to 800 
cm-1, representing combinations of diverse functional  groups.  
 
Based on the identification of the most relevant spectral bands 
on the PCA loading vectors, it was subsequently evaluated 
diverse ratios of spectral bands, as this dimensionless ratio 
minimizes the effect of the spectra baseline distortion and 
sample quantity. For simplicity, the annotation Axx represents 
the absorbance at the wavenumber xx. Fig. 2 represents some 
of these absorbance ratios observed before and after 90 days of 
EGCG consumption. 
 
It was observed that the following spectral ratios discriminate 
the plasma between T0 and T90 at a significance of 1 %: From 
the fingerprint region, A455/A478, A594/A621, A664/A700 
and A700/A743; from the amide A and lipids region, 
A3076/A3300, A2966/A3300 and A2966/A3076; the 
A1170/A1547 representing the ratio between RNA and 
proteins; and diverse ratios relative to phosphate groups (1083 
and 1240 cm-1) in relation to amide I and II as A1240/A1547, 
A1083/A1547 and A1083/A1650. This highlights the high 
impact of EGCG consumption on the whole plasma molecular 
composition. These observations are in accordance with the 
high impact of EGCG on the general cell metabolism as on 
metabolic enzymes associated to glycolysis, pentose 
phosphate pathway and serine biosynthesis [12], mitochondria 
energetic metabolism [13], lipid metabolism and lipid 
peroxidation [14,15], cell division and apoptosis [16].  
 
 
 
Fig. 2 presents data from some ratios of absorbance observed 
before and after 90 days of EGCG consumption, statistically 
different at 1% significance: The A2966/A3076 representing 
the ratio between methyl group of lipids and amide A of 
proteins; A1083/A1650, representing the ratio between 
phosphate groups and amide I of proteins; A1083/A1240, 
representing the ratio between symmetric and asymmetrical 
vibrations of phosphate groups and A594/A621 from the 
fingerprint region. 
 
 
 
 
Fig. 2.  Box-whiskers representation of median and other quartiles of some 
ratios of absorbance bands observed before the EGCG consumption (blue 
boxes) and after 90 days of consumption (orange boxes).  
 
 
In resume, the presented method, based on MIR spectroscopy, 
enabled to capture the whole plasma molecular signature in a 
highly specific and sensitive mode. Since the MIR spectra is 
acquired based on an economic, simple, fast and high-
throughput technique, it can be applied in vivo large-scale 
studies in order to further understand the metabolic impact of 
EGCG consumption.  
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